FTLF FITLIFE BRANDS, INC.
FY2024 10-K
FITLIFE BRANDS, INC. (FTLF) filed its fiscal year 2024 10-K annual report with the SEC on Mar 27, 2025. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2024 10-K
Business Overview
- • Core business: provider of proprietary nutritional supplements and wellness products marketed under multiple brands across sports, weight loss, and general nutrition
- • New segment additions: acquired MRC Brands in Feb 2023 and MusclePharm assets in Oct 2023, expanding e-commerce and wholesale distribution
Management Discussion & Analysis
- • Revenue $64.5M, up 22% YoY from $52.7M; growth driven by acquisitions of MRC & MusclePharm, Legacy FitLife down 10% to $25.4M
- • Gross margin improved to 43.6% vs 40.7% YoY; gross profit increased 31% to $28.1M from $21.4M
Risk Factors
- • Regulatory risk: FDA dietary supplement regulations with no pre-sale product approval, potential safety or efficacy issues affecting product acceptance and liability
- • Macroeconomic risk: 66% sales dependence on Amazon U.S. Marketplace, changes in Amazon fees or policies could materially impact revenue
Financial SummaryXBRL
Revenue
$64M
Net Income
$9M
Gross Margin
43.6%
Operating Margin
20.3%
Net Margin
13.9%
ROE
24.9%
Total Assets
$59M
EPS (Diluted)
$0.91
Operating Cash Flow
$10M
Source: XBRL data from FITLIFE BRANDS, INC. FY2024 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on FITLIFE BRANDS, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.